phenotypeId,phenotypeName,clinicalDescription
134442000,Systemic sclerosis,"Overview: is the presence of presence of thickened, hardened skin and is the hallmark of ‘Systemic Sclerosis’. Systemic Sclerosis (SSc) is a multisystem disease characterized by progressive fibrosis of skin and internal organs. Presentation: Skin manifestations are universal in Systemic Sclerosis (SSc) but the extent and degree may vary. Symptoms of systemic involvement may appear later – commonly lung disease related breathless on exertion, nonproductive cough. Raynaud’s phenomenon is commonAssessment: Common serologic markers are Antinuclear antibody (95% sensitivity), Antitopoisomerase I (anti-SCL-70) antibody positivity, anticentromere antibody, anti-RNA polymerase III antibody. Plan: customized treatment tailored to individual patients, that involves systemic immunosuppressive therapy. Prognosis: Progression of systemic disease may lead to mortality. This is a long-term progressive disease."
